XPhyto Announces Business Strategy and Milestones For 2021 Innovation to Impact
The Pharma Data
JANUARY 17, 2021
Clinical validation of transdermal and sublingual drug formulations. Psychedelic API production, drug formulation and clinical integration. Drug Formulations and Delivery. Commercialization of rapid COVID-19 PCR test. Diagnostics. “2020 was a very productive year for XPhyto. .
Let's personalize your content